Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,245 across all filing types
Latest filing 2022-02-18 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
We wish to inform you that the Company has received an approval of 'Certificate of GMP Compliance of a Manufacturer' from Therapeutic Goods Administration (TGA), Department of Health, Australia ....
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to the stock exchange listing department informing about the receipt of a GMP Compliance Certificate from the Therapeutic Goods Administration (TGA) for a manufacturing unit. It is an announcement of a regulatory compliance event rather than a financial report or detailed filing. The document length is only 1155 characters, indicating it is a brief notice. There is no financial data, no mention of annual or quarterly results, no voting or management changes, and no detailed report attached or referenced. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-02-18 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the intimation of loss of share certificate and the issuance of a duplicate share certificate. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about a shareholder's lost share certificate and the procedural update for issuing a duplicate. This is a regulatory announcement related to shareholding records and does not contain financial data, management changes, voting results, or other report types. It is not a report or announcement of financial results, nor a management or board change. It fits best under Regulatory Filings (RNS) as a compliance-related notification that does not fit other categories.
2022-02-11 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the loss of a share certificate and the issuance of a duplicate share certificate. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is an announcement of a specific shareholder's lost share certificate and the company's action to issue a duplicate. It does not contain financial data, management discussion, voting results, or any report publication. It is a regulatory compliance notification related to share certificates, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Share Issue/Capital Change or Director's Dealing.
2022-02-11 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 100% confidence The document is titled as "Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended December 31, 2021" and contains detailed financial data including standalone and consolidated financial results for the quarter and nine months ended December 31, 2021. It references Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs quarterly financial results disclosures. The document includes actual financial figures such as total income, profit before tax, net profit, earnings per share, and notes explaining exceptional items and accounting standards used. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a financial report rather than a brief announcement or certification. The content matches the characteristics of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and provides comprehensive financial data and analysis. Therefore, the correct classification is Interim / Quarterly Report (IR).
2022-01-31 English
Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper ....
Interim / Quarterly Report Classification · 95% confidence The document is titled as "Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended December 31, 2021" and contains detailed financial data including standalone and consolidated financial results for the quarter and nine months ended December 31, 2021. It references Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs quarterly financial results disclosures. The document includes profit, income, equity share capital, earnings per share, and notes explaining the figures. It is an extract of unaudited financial results, which is typical of an Interim / Quarterly Report. The document is about 15,000 characters long, contains substantive financial data and analysis, and is not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-01-31 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Outcome of Board Meeting held on Saturday, January 29, 2022' and mentions the approval of 'Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2021.' It references Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which govern disclosure of quarterly financial results. The document includes the financial results and the Limited Review Report of the Auditors, indicating it contains substantive financial data for a period shorter than a full fiscal year (quarter and nine months). This matches the definition of an Interim / Quarterly Report (IR). The document length is 15,000 characters, indicating it is not a brief announcement but contains detailed information. Therefore, the correct classification is IR (Interim / Quarterly Report).
2022-01-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.